EUVIMEDEUVIMED entdecken
Crossref

China rewrites its regulatory framework for stem cell clinical translation

Ruohan Feng, Xue Pang, Yi Hao, Tong Zhao, Yaojin Peng

Cell Stem Cell · 2026-11 · 33 (11) · 1748-1752

DOI: 10.1016/j.stem.2026.09.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2026-11. Verfasst von Ruohan Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Beijing Inst…. Hauptthemen laut MEDLINE: Translational Research, Biomedical, Stem Cells, Stem Cell Transplantation, Stem Cell Research. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Translational Research, BiomedicalStem CellsStem Cell TransplantationStem Cell ResearchHumansChina

Autor:innen und Institutionen

  • State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
  • State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of the Chinese Academy of Sciences, Beijing 100049, China.
  • Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
  • State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China;…

Zitieren

APA

Feng, R., Pang, X., Hao, Y., Zhao, T., & Peng, Y. (2026). China rewrites its regulatory framework for stem cell clinical translation. Cell Stem Cell, 33(11), 1748-1752. https://doi.org/10.1016/j.stem.2026.09.017

Vancouver

Feng R, Pang X, Hao Y, Zhao T, Peng Y. China rewrites its regulatory framework for stem cell clinical translation. Cell Stem Cell. 2026;33(11):1748-1752. doi:10.1016/j.stem.2026.09.017

BibTeX
@article{Feng2026,
  author = {Feng, Ruohan and Pang, Xue and Hao, Yi and Zhao, Tong and Peng, Yaojin},
  title = {China rewrites its regulatory framework for stem cell clinical translation},
  journal = {Cell Stem Cell},
  year = {2026},
  volume = {33},
  number = {11},
  pages = {1748--1752},
  doi = {10.1016/j.stem.2026.09.017}
}
Kostenlos starten →